L. Baumbach et al., CLINICAL, BIOCHEMICAL, AND MOLECULAR INVESTIGATIONS OF A GENETIC ISOLATE OF GROWTH-HORMONE INSENSITIVITY (LARONS SYNDROME), The Journal of clinical endocrinology and metabolism, 82(2), 1997, pp. 444-451
We have characterized the GK receptor mutation that is responsible for
extreme short stature and GH insensitivity in a Bahamian tic isolate.
Heights of affected individuals ranged from -4.0 to -6.3 SD. Like oth
ers with Laron's syndrome, they had normal to high serum GH concentrat
ions and low serum insulin-like growth factor I concentrations. Circul
ating levels of GH-binding protein activity were below limits of detec
tion. Amplification of exons 2-7 and screening with single strand conf
ormational polymorphism analysis located an abnormality in exon 7. Seq
uencing identified homozygosity for a C to T transition in the third p
osition of codon 236. Reverse transcription and PCR amplification of c
omplementary DNA from lymphocytes showed that this same sense mutation
generated a new splice donor site 63 bp 5' to the normal exon 7 splic
e site. This novel site was used to the exclusion of the normal site i
n homozygotes. Both normal and variant messenger ribonucleic acid spec
ies were detected in heterozygotes. The predicted protein lacks 21 ami
no acids, including those defining the WS-like motif of the GH recepto
r extracellular domain. The high frequency of Laron's syndrome in this
isolated island population probably reflects the introduction of the
G236 splice mutation by a settler early in the 300-yr history of Engli
sh settlement.